Education
About Us
Working with TipRanks
Follow Us
StemRIM Inc. (JP:4599)
:4599
4599 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥246.00 - ¥494.00
Previous CloseN/A
Volume121.60K
Average Volume (3M)236.60K
Market Cap
¥19.82B
Enterprise Value¥11.54B
Total Cash (Recent Filing)¥8.02B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta1.10
Next Earnings
Jun 11, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-33.50
Shares Outstanding62,136,200
10 Day Avg. Volume115,950
30 Day Avg. Volume236,596
Financial Highlights & Ratios
PEG Ratio-3.44
Price to Book (P/B)2.35
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
StemRIM Inc. News
PremiumCompany Announcements
StemRIM Secures European Patent for Cartilage Disorder Treatment
PremiumCompany Announcements
StemRIM Inc. Announces Shareholder Meeting and Capital Reduction
PremiumCompany Announcements
StemRIM Secures Chinese Patent for Redasemtide, Boosting Global ExpansionPremiumCompany Announcements
StemRIM’s Redasemtide Trial Advances with Promising Interim Results
PremiumCompany Announcements
StemRIM Inc. Reports Financial Loss Amid Ongoing R&D Investments
PremiumCompany Announcements
StemRIM Amends Phase 2b Trial Protocol for Stroke TreatmentPremiumCompany Announcements
StemRIM Extends Research to Advance Skin Anti-Aging Solutions
PremiumCompany Announcements
StemRIM Begins Phase 2 Trial for Cardiomyopathy TreatmentOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
99.97% Public Companies and
Individual Investors
4599 FAQ
What was StemRIM Inc.’s price range in the past 12 months?
StemRIM Inc. lowest stock price was ¥246.00 and its highest was ¥494.00 in the past 12 months.
What is StemRIM Inc.’s market cap?
StemRIM Inc.’s market cap is ¥19.82B.
When is StemRIM Inc.’s upcoming earnings report date?
StemRIM Inc.’s upcoming earnings report date is Jun 11, 2025 which is in 6 days.
How were StemRIM Inc.’s earnings last quarter?
StemRIM Inc. released its earnings results on Mar 12, 2025. The company reported -¥7.89 earnings per share for the quarter, missing the consensus estimate of N/A by -¥7.89.
Is StemRIM Inc. overvalued?
According to Wall Street analysts StemRIM Inc.’s price is currently Overvalued.
Does StemRIM Inc. pay dividends?
StemRIM Inc. does not currently pay dividends.
What is StemRIM Inc.’s EPS estimate?
StemRIM Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does StemRIM Inc. have?
StemRIM Inc. has 62,136,200 shares outstanding.
What happened to StemRIM Inc.’s price movement after its last earnings report?
StemRIM Inc. reported an EPS of -¥7.89 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.592%.
Which hedge fund is a major shareholder of StemRIM Inc.?
Currently, no hedge funds are holding shares in JP:4599
Company Description
StemRIM Inc.
StemRIM, a biotechnology company, develops regeneration medicines for the treatment of intractable diseases. It develops PJ1, a regeneration induction medicine HMGB1 peptides, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, osteoarthritis, and chronic liver disease, as well as cardiomyopathy; PJ2, a regeneration-inducing medicine novel peptides A and B; PJ3, a biologic regeneration-inducing protein; PJ4, an autologous cell sampling device for medical treatment; and PJ5, a stem cell gene therapy. StemRIM was incorporated in 2006 and is based in Ibaraki, Japan.
Technical Analysis
Renascience Inc.
―
ReproCELL Inc.
―
StemCell Institute
―
Japan Tissue Engineering Co., Ltd.
―
CellSeed Inc.
―